Melatonin in animal models by Pévet, Paul
he Earth’s rotation on its axis,the orbit of the
Earth around the Sun,and the orbit of the Moon around
the Earth induce rhythmic geophysical phenomena.
Organisms are thus affected by daily and seasonal vari-
ations of many physical factors of their environment.The
ability to adapt to this changing environment is an essen-
tial survival mechanism.As a result,life has evolved to
adapt to periodically changing environmental demands,
and to anticipate them according to their predictability.
Circadian and seasonal rhythms in biochemical,meta-
bolic,endocrine,physiological,and behavioral processes
are a fundamental feature of all living organisms,reflect-
ing the need to ensure that biological functions occur at
a given time of the day or year.The most obvious exam-
ple is the fact that many animals are active only during
the light period (diurnal species;human belong to this
group) or in the dark period (nocturnal species),and are
inactive during the other part of the day (sleep/wake
cycle).Other rhythms,such as reproduction,diapause,
hibernation,fur color changes,and migration,can also be
given as examples.Precise timing is required at all levels
from behavior to gene expression,and its dysregulation
causes malfunction.
Since the beginning of time,mankind has been fascinated
by the sun and the invariably changing seasons, and
ancient medical scripts include considerations on the vari-
ation of disease through the seasons.Disorders of rhyth-
micity are characteristic of—and may underlie—a variety
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T
Melatonin is a hormone synthesized and secreted during
the night by the pineal gland. Its production is mainly dri-
ven by the circadian clock, which, in mammals, is situated
in the suprachiasmatic nucleus of the hypothalamus. The
melatonin production and release displays characteristic
daily (nocturnal) and seasonal patterns (changes in dura-
tion proportional to the length of the night) of secretion.
These rhythms in circulating melatonin are strong syn-
chronizers for the expression of numerous physiological
processes. In mammals, the role of melatonin in the con-
trol of seasonality is well documented, and the sites and
mechanisms of action involved are beginning to be iden-
tified. The exact role of the hormone in the diurnal (cir-
cadian) timing system remains to be determined.
However, exogenous melatonin has been shown to affect
the circadian clock. The molecular and cellular mecha-
nisms involved in this well-characterized “chronobiotic”
effect have also begun to be characterized. The circadian
clock itself appears to be an important site for the entrain-
ment effect of melatonin and the presence of melatonin
receptors appears to be a prerequisite. A better under-
standing of such “chronobiotic” effects of melatonin will
allow clarification of the role of endogenous melatonin
in circadian organization.
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and circadian rhythms are often disrupted in neurological
disorders and there is increasing evidence that alterations
in the sleep/wake cycle accompany many types of neuro-
logical disorders.Moreover,in our modern human society,
there is an increasing incidence of “circadian misalign-
ment”caused by behaviors that perturb the relationship
between light-mediated and activity-related input to the
circadian system (eg,delayed resynchronization to local
time [jet lag] or shift work rotation associated with gen-
eral malaise [especially insomnia] and decrements in work
productivity and increases in accidents).
1Additionally,in
our aging society,there is a high incidence of circadian dis-
orders,particularly disturbed sleep patterns,which reduce
the quality of life. Moreover clinical responses to drug
therapies,including those for cancer,
2 can crucially depend
on the state of the patient’s circadian system.
The challenge for scientists is to understand the func-
tional mechanisms involved and develop strategies to
control or treat these disorders,which have important
economic and health consequences.
The functional mechanism used for the daily or seasonal
organization of functions is far from well understood.We
now know that, in mammals, these adaptive processes
are organized within a circadian network comprising an
endogenous self-sustained oscillator,synchronizing clock
inputs, and various clock outputs.The major circadian
oscillator is located in the suprachiasmatic nuclei (SCN)
of the hypothalamus and the decoding of its genetic
background is underway.Photic and nonphotic inputs act
directly or indirectly on the rhythms of clock gene
expression to synchronize the circadian oscillations to
exactly 24 h.
3The most efficient synchronizer is the daily
light/dark (LD) cycle, but other factors, such as food
restriction,locomotor activity,and chronobiotic drugs,
are well-defined clock synchronizers as well.
4The circa-
dian oscillator outputs allow the internal synchronization
and temporal organization of physiological,endocrine,
and behavioral functions.From the hypothalamic clock,
various efferent pathways have been described,one of
the most important reaching the pineal gland. This
endocrine structure synthesizes and releases melatonin.*
Melatonin is synthesized and secreted during the dark
period of the LD cycle,independent of whether the ani-
mal is diurnally or nocturnally active,and the duration
of the nocturnal production is proportional to the length
of the night.
8,9 Melatonin is thus an important efferent
hormonal signal from the clock and its pattern of secre-
tion provides both a daily and seasonal endocrine mes-
sage to any structure or organ that can “read”it.It is now
well established, as will be discussed below, that these
messages are directly involved in the regulation of both
circadian and seasonal rhythms in mammals.
Before we start the description of current knowledge,it
should be mentioned that, at high doses, exogenously
administered melatonin has been reported to be a potent
free radical scavenger.
10,11 This effect can be explained
through direct scavenging of free radicals or through
interactions of enzyme that improve total antioxidative
defense capacity.Even though the physiological nature
of such an effect could be questioned,it should not be
neglected when assessing the therapeutic potential of the
hormone,
12 especially because the binding of melatonin
to quinone reductase (QR2), an enzyme with well-
known oxidoreductive properties, has recently been
demonstrated.
13
Melatonin and seasonal function
The duration of the peak of melatonin secretion is pos-
itively correlated with the length of the night period.
Experimentally,it has been demonstrated that the brain
is able to integrate photoperiodic information through
these changes in duration of melatonin synthesis.This
explains the current use of this hormone in farming to
control seasonal functions (eg,fur growth,reproduction,
and milk production).This also opens therapeutic per-
spectives if we consider the hypothesis of Wehr
14 that
“the photoperiod-induced changes in the duration of
melatonin secretion drive the annual cycle that occurs in
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Selected abbreviations and acronyms
DMH dorsomedial hypothalamus
LD light/dark
LH luteinizing hormone
PT pars tuberalis
SCN suprachiasmatic nucleus
SP short photoperiod
*Although the pineal gland is the major source of melatonin, other sources
do exist. The retina is one such extrapineal source.
5,6 However, and contrary
to what happens in some nonmammalian vertebrates, mammalian retinal
melatonin does not contribute to circulating melatonin. The Harderian and
lachrymal glands, gastrointestinal tract, red blood cells, platelets, and
mononuclear cells have also been identified as sites of melatonin synthe-
sis. Melatonin does not appear to be released into the general circulation
from these tissues, at least under normal physiological conditions.
7
Moreover, the synthesis of melatonin in these tissues does not appear to
be rhythmic.Melatonin in animal models - Pévet  Dialogues in Clinical Neuroscience - Vol 5 . No.4 . 2003
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seasonal affective disorders.”The exact mechanism of
action of melatonin is unclear.The duration of nocturnal
melatonin production is the key signal,
8 but the existence
within this signal of a melatonin-driven circadian rhythm
of sensitivity to melatonin has been proposed to explain
the photoperiodic response.
15 In fact,our understanding
of melatonin’s physiological functions depends on the
understanding of how and where its action is exerted.
Considering the lipophilic nature of the hormone,inter-
actions with specific intracellular proteins
16,17 or nuclear
receptors cannot be excluded;however,melatonin seems
to exert its effects principally throughout high-affinity 
G-protein–coupled receptors. The introduction of 
2-[
125I]iodomelatonin (
125I-Mel)
18 heralded the develop-
ment of the melatonin receptor field.The cloning of the
first high-affinity melatonin receptor in 1994 by Ebisawa
et al
19 then led to the subsequent identification of three
types of vertebrate melatonin receptors (MT1,MT2,and
Mel1c),and this very probably is only the beginning of a
long list.Considering the photoperiodic responses,the
melatonin receptors involved most probably are of the
MT1 subtype.Indeed,the gene of the only other mela-
tonin receptor subtype found in mammals,MT2,is non-
functional in two highly photoperiodic species,Siberian
and Syrian hamsters (Weaver and Reppert,unpublished
data cited in reference 20).The target sites mediating
melatonin control of photoperiod-dependent seasonal
functions and especially the annual sexual cycle have not
yet been totally determined.Contrary to what is gener-
ally claimed,melatonin receptors are present in a large
number of structures in mammals (more than 110 brain
structures have been identified,among them the internal
granular layer and the external plexiform layer of the
olfactory bulb,lateral septum,septohippocampal nucleus,
caudate putamen, bed nucleus of the stria terminalis,
SCN,mediobasal hypothalamic nuclei,paraventricular
nuclei of the hypothalamus,paraventricular nuclei of the
thalamus, intergeniculate leaflet, central and medial
amygdaloid nucleus, inferior colliculus, fasciculus
retroflexus,substantia nigra,and frontal,orbitofrontal
and parietal cortex; numerous peripheral organs also
contain melatonin receptors
21-25).However,a great vari-
ability has been noted in the number and location of
structures among the species,as well as large differences
in receptor density between structures and in the same
structures between species.Few structures are common,
even among species from the same family,
21 and very
probably this should be correlated to either the numer-
ous photoperiodic responses, which are different from
one species to another, or the many different effects
described for melatonin.
One structure, however, the pars tuberalis (PT) of the
pituitary,which contains a very high density of melatonin
receptors in all mammals studied,is thought to be of pri-
mary importance in photoperiodic response.Its density
of melatonin receptors exhibits clear seasonal changes in
photoperiodic species,but not in nonphotoperiodic mam-
mals,
26,27 and its implication in the control of seasonal
secretion of prolactin has been demonstrated.
28-31The PT
is thus a good model to delineate the melatonin’s signal
transduction pathways
32,33 and to study how the cellular
response can distinguish between long- and short-dura-
tion melatonin signals.
The cyclic adenosine monophosphate (cAMP)-mediated
pathways appear to be central to the melatonin readout.
Pretreatment with melatonin has been demonstrated to
induce a sensitization of adenylate cyclase,and a poten-
tiated cAMP response to forskolin stimulation.
34,35
Melatonin pretreatment that is effective in potentiating
cAMP accumulation in the PT is duration-dependent
(between 0-16 h) and corresponds well with the duration
of the nocturnal melatonin signal.
34The nocturnal mela-
tonin signal is also crucial for the rhythmic expression in
the PT of several cAMP-responsive genes,including the
transcriptional inhibitor–inducible cAMP early repres-
sor (ICER),and of several clock genes.
36,37 Indeed,two
components of the molecular clock, namely Per1 and
Cry1,are rhythmically expressed in the PT.Furthermore,
other components of the clock like Timeless,Clock,and
Per2 (Pévet P et al,unpublished observations) are also
expressed in the PT,at least in the PT of some rodents,
raising the possibility that the PT might contain a com-
plete set of clock genes.
33,36,38-41 However,the clock gene
expression in the PT differs from what is observed in the
SCN or other peripheral tissues (peripheral oscillators)
because it appears to be directly driven by melatonin.
Removal of the pineal gland abolishes rhythmic PT gene
expression,and extension of the dark phase of the LD
cycle dampens the amplitude of the Per1 in PT cells.
39
Cry1 is rapidly and very strongly induced by melatonin
administration.In nontreated animals,a peak of expres-
sion occurs during the dark phase (ie, at a time when
melatonin is present in the bloodstream).This indicates
that melatonin may gate the expression of Cry1 in the
PT,suggesting that these clock genes are involved in the
melatonin readout mechanism.Cry1 expression appearsto be anchored to the onset of melatonin secretion.It acts
as a sensor of melatonin onset,rather than a marker of
the duration of the melatonin signal.
Per1 mRNA peaks early in the day,when blood plasma
melatonin levels are back to low levels.Per1 expression
thus appears to be linked to the offset of melatonin secre-
tion.This dual effect of melatonin together with its pho-
toperiod-dependent pattern in plasma levels may provide
the basis of a time measurement mechanism.This model
may help understand how the PT is involved in the sea-
sonal control of prolactin secretion by the PT.The vali-
dation of such a model will, however, require further
experiments and the complete understanding of the
melatonin and photoperiodic readout requires a link with
identified downstream response in the PT.This is still dif-
ficult.It is through the production of a prolactin-releas-
ing (or release inhibitor) factor that the photoperiodic
and melatonin information to lactotroph cells in the pitu-
itary are relayed.This factor,termed “tuberalin,”
30,42 has
not yet been identified.
Photoperiod-induced changes in prolactin secretion,
however,are not enough to explain the seasonal sexual
cycle.This implies that in order to mediate photoperiodic
information melatonin must act on other target sites.This
view is supported by the fact that Syrian hamsters bear-
ing lesions to the dorsomedial hypothalamus (DMH) and
infused with melatonin to mimic short photoperiod (SP),
display differential responses in terms of prolactin and
luteinizing hormone (LH).
43While the prolactin response
remains intact,the LH response in blocked by the DMH
lesion.
43 Moreover,in sheep,melatonin implants in the
mediobasal hypothalamus block the effects of SP on LH
but not on prolactin, while implants close to the PT
inhibit prolactin secretion.
44 Interestingly,melatonin bind-
ing sites have been detected in the DMH in the Syrian
hamster,although with a very low density,and their den-
sity depends on the photoperiod (Pévet P et al,unpub-
lished data).
The hypothesis of a parallel and concomitant action of
melatonin on different structures to transduce the pho-
toperiodic message is attractive. The photoperiod is
known,through changes in duration of melatonin secre-
tion,to control not only the reproductive annual cycle,but
also a large number of other seasonal functions (eg,body
weight,hibernation,daily torpor,fur color changes,and
migration).Furthermore,not all seasonal functions are
expressed in every species and different control mecha-
nisms may be involved.For example,SP induces an acti-
vation of the sexual axis in sheep,but inhibition in Syrian
and Siberian hamsters; and hibernation in the Syrian
hamster is directly dependent on photoperiod,while in
the European hamster it is dependent on a “circannual
clock”entrained by photoperiod.It thus seems likely that
melatonin acts at different structures according to the
species and the function.This concept would account for
the large interspecies differences observed in mammals
in the distribution of structures containing melatonin
receptors.Interestingly,and in support of this concept,a
pharmacological dissociation of photoperiodic-controlled
seasonal functions has been reported. S 22153, a mela-
tonin antagonist of MT1 and MT2 melatonin receptor
subtypes,caused a decrease in the duration of hibernation
in Syrian hamsters under SP and low temperature,but did
not affect SP-induced gonadal atrophy.
45
Melatonin and circadian function
In most nonmammalian vertebrates,the rhythmic syn-
thesis and secretion of melatonin is the direct output of
circadian clock,and the rhythmic changes in the concen-
tration of circulating melatonin are fundamental to cir-
cadian rhythmicity.
46 In mammals,despite the presence
of melatonin receptors in the SCN of most species indi-
cating hormonal feedback on the clock, the consensus
has been that melatonin has only a limited role in circa-
dian organization. This view has arisen, in part, since
pinealectomy has little effect on circadian organization.
47
Melatonin rhythm,however,is only one of the outputs of
the clock and it is probable that,for the organization of
circadian activities,a number of different output signals
from the clock are involved in the distribution of circa-
dian information to target tissues.
48,49This does not pre-
clude an important role for melatonin in circadian orga-
nization.
36 After pinealectomy, for example, subtle
desynchrony of several physiological functions has been
described,
50 and the reentrainment of the rat locomotor
activity rhythm is modified after a phase shift of the LD
cycle.
51 One week after pinealectomy, the firing rate
rhythm of SCN neurons in vitro is altered,as well as the
daily rhythm of responsiveness to melatonin.
52 It is also
known that melatonin interferes with metabolic activity
(glucose utilization and protein synthesis) in the SCN.
53
The SCN may use the daily melatonin signal to convey
the circadian message to any system that can “read”it,ie,
to any structure or organ possessing melatonin receptors,
either in the central nervous system or at the periphery.
9,54
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ature:the melatonin inhibition of spontaneous and light
evoked activity of cells in the intergeniculate leaflet
55;
melatonin-enhancing splenic lymphocyte proliferation
56,57;
melatonin-induced inhibition of leukocyte rolling and
adhesion to rat microcirculation
58; melatonin-induced
vasoconstriction of cerebral and tail arteries
59;and mela-
tonin regulation of emotional behavior.
60
What could be the mechanism involved? Clock genes are
expressed widely in mammalian tissues.It appears that
cyclical expression of these genes in the periphery is dri-
ven by the SCN. The role of melatonin in regulating
rhythmic clock gene expression in peripheral tissues as
described in the PT (see above) may be one of the mech-
anisms for tissue-specific regulation of the phase of
rhythmicity.Interestingly,it has been demonstrated that
the circadian rhythm of melatonin receptor density in rat
PT is suppressed after pinealectomy and melatonin 
drives this rhythm directly.
61,62 Even if the role of endoge-
nous melatonin on clock functioning is not yet defined,
the presence of melatonin receptors within the SCN indi-
cates that exogenous melatonin affects circadian regula-
tion,which is of potential therapeutic value.
Exogenous melatonin and circadian rhythms
Exogenous melatonin is known to be able to influence,
directly or indirectly,the phase and/or the period of the
circadian clock. In terms of treatments, this means that
exogenous melatonin (or any agonist) can be used as a
pharmacological tool to manipulate sleep-wake cycle
and other circadian rhythms (chronobiotic properties
63).
It has long been known that administration of melatonin
can entrain free-running activity rhythms in rodents.
20,64
Entrainment means that the period of the observed
rhythm must adjust to,and equal,the synchronizer (zeit-
geber) cycle (T), and a stable phase relation must be
established between the rhythm and the zeitgeber cycle.
This synchronization process occurs through daily phase
shifts.Administering melatonin for a series of T values,
24 h, 23 h 50 min, 23 h 45 min, 23 h 35 min, and 23 h 25
min
65 has led to the definition of the limiting phase
advance value to which the rat activity rhythm entrains
to melatonin at 35 min.The entrainment limits found in
this study correspond quite well to the maximum daily
phase shift values defined by the melatonin phase
response curve,
66 and the magnitude of phase shift
responses to a single melatonin injection
67 (range 15-52
min). Daily acute melatonin administration in the rat
thus causes “true” entrainment as defined by Enright 
et al.
68
Interestingly,when melatonin is administered by daily
infusion, the phase angle difference between the
entrained rhythm and the zeitgeber (melatonin) depends
upon the duration of the infusion period. A negative
phase angle is observed and its value increases with the
duration of the infusion period.
69 Moreover, with long
infusion times (8 h and,more especially,with 16 h),mela-
tonin induces a change in the free-running period in the
first days, suggesting that melatonin delays the pace-
maker each day until entrainment occurs.In other words,
with a long duration of infusion,entrainment occurs ear-
lier than predicted by the model based on acute mela-
tonin administration.The magnitude of the change in
period increases significantly with the duration of infu-
sion.These observations suggest that,beside its chrono-
biotic properties,melatonin affects the circadian clock
properties (effect on the period τ?).This conclusion is
supported by the results obtained after a “skeleton”infu-
sion.Under these conditions,melatonin induced entrain-
ment after a time during which circadian periods were
either lengthened (in a fraction of the animals) or short-
ened (in the others).
69 This finding suggests that, to
achieve entrainment, melatonin has to induce either a
phase delay (when the period is shortened) or a phase
advance (when the period is lengthened). Such a dual
effect of melatonin has also been reported in other stud-
ies.For example,when rats received a 5 h phase advance
of the dark onset in LD conditions,those injected mela-
tonin daily at the new dark onset reentrained with
decreased latency;some of the animals did so by phase
delays, whereas others did so by phase advances.
66
Melatonin has been reported to entrain hamsters and
Arvicanthis ansorgei,a diurnal rodent,by inducing phase
advances when the free-running period is longer than 24 h
and phase delays when the period is shorter than 24 h.
70-72
All these observations strongly suggest that the effects of
exogenous melatonin are complex and depend on the
period before entrainment.
Another potential effect of exogenous melatonin should
be considered.A single application of melatonin within
the SCN,in vivo,induced a long-lasting increase in the
amplitude of the nocturnal melatonin secretion.
73 This
effect demonstrates that exogenous melatonin is able to
sustain the oscillation of the clock and suggests a possi-
ble role for endogenous melatonin in mammals.
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the circadian activities
In the experiments reported above, responsiveness to
melatonin is restricted to a narrow window of sensitivity,
which is generally late in the subjective afternoon,but
depends upon the duration of the melatonin signal as
well as the previous free-running period.The finding that
pinealectomized rats entrain to daily melatonin admin-
istration
67,69 indicates that endogenous melatonin is not
necessary for the entrainment effect of exogenous mela-
tonin,for example,by entraining a window of sensitiv-
ity to melatonin.
15 Nocturnal melatonin production is a
direct output of the SCN circadian clock. Exogenous
melatonin is effective at a time when endogenous mela-
tonin is not produced.Consequently,the effects of mela-
tonin administration in vivo appear not to be related to
the role of endogenous melatonin on circadian function.
This conclusion is reinforced by the observation that to
obtain entrainment of the circadian activity rhythm of
rodents kept under constant darkness (DD),high doses
of melatonin have to be used,independently of the mode
of administration.
69,74,75These doses of melatonin produce
peak serum levels 100- to 1000-fold higher than the
endogenous melatonin nighttime levels.The necessity of
such a high dose of melatonin is unlikely to be a conse-
quence of its rapid metabolism.Appropriate photoperi-
odic response is indeed obtained when melatonin is
administered via a similar subcutaneous infusion system
with a dose that mimics the endogenous secretion pro-
file.
15,76 Most likely,this high dose of melatonin is needed
because it is an integral part of the response observed.
In vitro administration of melatonin can phase shift the
firing rate of SCN neuron brain slices (rat and mouse).
77,78
It is principally for this reason that it is generally believed
that melatonin mediates these effects through the high-
affinity melatonin receptors located within the SCN.
61,79
The high correlation between the density of melatonin
receptors within the SCN and the ability of daily mela-
tonin administration to entrain the free-running activity
rhythm in mammals supports this view.In contrast to the
rat,mouse,and Djungarian hamster (rodents that can be
entrained by daily melatonin administration and in which
a high density of melatonin receptors is observed within
the SCN),the mink (Mustela vison) does not appear to
have specific melatonin receptors (at least 2-iodomela-
tonin binding sites) within the SCN.This animal does not
entrain to melatonin.
80 Newborn Syrian hamsters express
melatonin receptors in the SCN,but the receptor num-
ber decreases shortly after birth.
81,82Young hamsters are
entrainable by daily acute melatonin administration,
while,in the adult,melatonin is unable to entrain
83,84 or
synchronize,except under particular experimental con-
ditions (eg, long-term infusions which affect the τ).
70,72
Since SCN-lesioned hamsters whose rhythmicity had
been restored with fetal hypothalamic graft are entrained
by daily melatonin injection,it is evident that the chrono-
biotic effect of exogenous melatonin is the consequence
of an action on the clock.This conclusion is supported by
the observation that in vivo a melatonin receptor antag-
onist (S 22153) blocks the phase-advancing effect of
melatonin.
85
Which receptor subtypes are involved? Siberian hamsters
without a functional MT2 receptor show circadian
responses to melatonin.
86 Similarly, the most robust
entraining response to melatonin, synchronization of
developing circadian pacemakers in Syrian hamsters by
melatonin injections,occurs in the absence of a functional
MT2 receptor within the SCN.
87This strongly suggests the
implication of MT1 receptors.In in vitro experiments in
animal models that possess both subtypes, the mecha-
nisms involved appear to be more complex. An acute
inhibitory effect on neuronal firing and a phase-shifting
effect in the rhythm in electrical activity have been
described.
88 In mice with a targeted deletion of the MT1
receptor,the acute inhibitory effect of melatonin was abol-
ished, while the phase-shifting effect remained intact.
88
However, this phase shift disappears when the MT2 
antagonist 4-phenylpropionamidotetraline (4P-PDOT) is
added.
89This suggests that either a low density of MT2
receptors is still capable of producing a phase shift or that
an as yet unidentified melatonin receptor subtype is
involved.In contrast to previous studies,van den Top et
al
90 have recently demonstrated the absence of a specific
window of sensitivity for melatonin to inhibit SCN neu-
ronal activity.This lack of a window of sensitivity con-
trasts with the phase-shifting effect of melatonin, and
indicates that the cellular mechanisms involved in the
acute inhibitory effect and in the phase-shifting effect of
melatonin are distinct.This may be related to the two
types of effects observed in vivo after daily 8 or 16 h
melatonin perfusions
69 described above.
The presence of MT1 and/or MT2 melatonin receptors
appears to be a necessary condition for the chronobiotic
effect of melatonin.However,if these high-affinity mela-
tonin receptors were the only mechanism involved, it
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would be difficult to explain why a pharmacological dose
of melatonin is needed. This implies that other neural
mechanisms may be involved.Although a strong modula-
tory role of exogenous melatonin on serotonin (5-hydroxy-
tryptamine) 5-HT receptor–mediated responses has been
reported,the 5-HT system does not appear to be crucial
to the effects of melatonin on circadian rhythms.
91
Conclusions and perspectives
Melatonin is produced nocturnally by the pineal gland,
in a pattern that reflects the phase and duration of the
night.The physiological roles of the hormone directly
relate to the temporal information it conveys. In fact,
nocturnal melatonin secretion is a hormonal output sig-
nal of the circadian clock able to convey photoperiodic
as well as circadian signals to multiple structures and
organs possessing melatonin receptors,within the brain
or at the periphery.This explains why melatonin appears
to act in so many different systems.
The use of melatonin to control seasonally expressed
traits of economic importance (milk and wood produc-
tion,etc) in farm animals is now well documented,and the
sites and mechanisms of action involved are beginning to
be identified.The exact role of the hormone in the circa-
dian timing system remains to be determined.However,
due to the presence of melatonin receptors within the
SCN itself,exogenous melatonin has been shown to affect
the circadian clock in animal models (chronobiotic effect).
The observations that, in humans, melatonin improves
some circadian-based disorders refer to such properties
and will lead to strategies to treat,prevent,or delay such
disturbances.Melatonin,as explained above,acts through
several mechanisms.The hormone’s physiological func-
tions—and thereby its therapeutic potential—will depend
on our knowledge of its mechanism of action.Today,the
pathways through which temporal information encoded
in the melatonin signal is decoded in target tissues,and
the phenotypic nature of those target tissues,are not com-
pletely understood.Experimental work in animal models
is still needed to define exactly the therapeutic value of
the hormone (for more perspectives with the use of phar-
macological tools based on melatonin receptors and 
α-antagonists see reviews in references 63 and 92). ❏
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circadiano. Los mecanismos moleculares y celulares
que participan en este efecto “cronobiótico” bien
caracterizado también han comenzado a ser identi-
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sites et mécanismes d’action commencent à être
bien identifiés. Le rôle exact de la mélatonine dans
l’organisation journalière des fonctions reste à
déterminer. Toutefois des administrations de méla-
tonine exogène sont connues pour agir sur le sys-
tème circadien. Les mécanismes moléculaire et cel-
lulaire impliqués dans cet effet « chronobiotique »
de l’hormone commencent à être identifiés.
L’horloge circadienne elle-même semble être la
cible principale et la présence de récepteurs à la
mélatonine est nécessaire. Déterminer ces méca-
nismes d’action permettra de clarifier le rôle de la
mélatonine endogène dans l’organisation circa-
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